SAN ANTONIO, TEXAS—May 29, 2007—Seno Medical Instruments, Inc., a San Antonio medical device company, announces its participation in the In3 Medical Device Summit taking place June 3–5. Seno Medical Instruments CEO, Janet Campbell, will present the company’s patented laser opto-acoustic medical imaging technology to attendees. Attendees will include some of the biggest dealmakers in the medical device industry, including members of the healthcare investment community.
Investors and fellow medical device executives will hear about Seno’s platform technology, which combines light and sound to produce high contrast images for cancer detection and treatment. This technology has a multitude of potential cancer applications which include breast, ovarian, prostate, colorectal, bladder and melanoma cancers. This innovative platform technology also has potential non-cancer applications in the areas of cardiovascular, inflammatory disease and stroke.
“We are excited to present our technology at this summit, known as the largest strategic partnership and investment meeting for medical technology executives. This summit is the most important venue of its kind for previewing cutting-edge emerging medical technology companies,” said Campbell, one of the first female CEO’s in the breast cancer imaging industry.
Seno’s initial imaging device for cancer researchers is expected to be released in the first quarter of 2008, with its breast cancer diagnostic to follow. The first clinical applications, breast cancer diagnosis and screening, will target a market estimated to be $5.9B (North America only).